Fasoracetam
Fasoracetam (NS 105) is the activator of metabotropic glutamate receptor (mGluR) . Fasoracetam (NS 105) has the potential for the research of attention-deficit hyperactivity disorder (ADHD) and Alzheimer's disease (AD) [1][2].
Product Specifications
CAS Number
[110958-19-5]
Product Name Alternative
NS 105
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/fasoracetam.html
Purity
99.41
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1NC(CC1)=O)N2CCCCC2
Molecular Formula
C10H16N2O2
Molecular Weight
196.25
Precautions
H302, H315, H319, H335
References & Citations
[1]Elia J, et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. Nat Commun. 2018;9 (1) :4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
125295-ML405 100 µL
CPSF6 (CFIM68, Cleavage and Polyadenylation Specificity Factor Subunit 6, Cleavage and Polyadenylation Specificity Factor 68kD Subunit, Pre-mRNA Cleavage Factor Im 68kD Subunit, Protein HPBRII-4/7) (MaxLight 405) discontinued
Sign In for Pricing
View Details